ET-73 ?? (Cancer Teaser, Michael Robinson, Nova-X Report)

By mrproby, August 26, 2016

What is Et-73, and what small biotech company is about to go IPO, that controls it?

This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.

40
Share your thoughts...

avatar
31 Comment threads
9 Thread replies
0 Followers
 
Most reacted comment
Hottest comment thread
27 Comment authors
Travis Johnson, Stock GumshoeCuriousklingo88spiritSoGiAm Recent comment authors

This site uses Akismet to reduce spam. Learn how your comment data is processed.

jimpsgs
Member
๐Ÿ‘11
jimpsgs

A small Biotech company claims that they synthesized the blood from a fish. The result is a compound produced that cures many types of cancer more effectively then present day procedures. This compound is called ET-47. The company is in trial level 3 and awaiting FDA approval. The biotech plans on issuing an IPO stock this year. There is away of purchasing this stock before it’s released to the market. The Money morning newsletter – Radical Technology Profits provides initial information but you have to signup for $1900 to get the complete data. Can anyone provide information as to biotech… Read more ยป

Add a Topic
3397
Add a Topic
3022
Add a Topic
636
Straydog
Guest

Right. Ever notice how everything at MONDAY MORNING costs $1950 ? They’re CREEPY.

izzy
Guest

Yes, they are! once they got your money – like a dog bitting’s the DONE.

Bozo T. Clown
Guest
Bozo T. Clown

PHMMF ET-743 Trabectedin Pharma Mar Janssen Pharma

Johnny Bingham
Guest
Johnny Bingham

Me neither. I am trying to find the reliable source about ET-73 but there’s nowhere to be found.

Schoir
Guest
Schoir

Ecteinascidia turbinata

stockinvestor
Member
๐Ÿ‘12
stockinvestor

here u are,
U.S. FDA Approves YONDELISยฎ (trabectedin – ET-73) for the Treatment. Dont buy any subscription from money morning guys, full of scam artists.

Add a Topic
3022
Add a Topic
3415
trevor martin
Guest

I second that–these guys are cons.

SoGiAm
Member
๐Ÿ‘11361

c http://www.stockgumshoe.com/2016/08/microblog-et-73/

john williams
Guest
john williams

Larry – You probably have a better chance of making money by buying $245 worth of lottery tickets. Similar videos have been circulating for months.

john williams
Guest
john williams

Convincing video. In fact, too convincing. Just think about it. 1. Pre-IPO for regular non-qualifying investors? 2. Only 400 positions available, so invest now? 3. Other videos circulating with different authors but similar products with same ET- but different numbers? Same $245 per unit price? 4. Special bank account created? 5. Just happened to be scuba diving in the Caribbean and decided to take just one of the hundreds of colorful fish home with him to do cancer research? These are just a few “red flags” to consider before throwing you money away.

Add a Topic
3397
kgarvey
Irregular
๐Ÿ‘15
kgarvey

Two companies pop up right away, PharMar and Johnson & Johnson. Clearly, J&J is not an IPO candidate. Don’t know about PharMar. But, I think John William’s comments are most introspective in this case.

Add a Topic
636
kgarvey
Irregular
๐Ÿ‘15
kgarvey

Correction: PharmaMar

Add a Topic
5350
Tim Stirrett
Guest
Tim Stirrett

I am an unexperienced investor but I do read a lot. How can I get in on the ground floor with the ET-73 YONDELIS investent with out having to buy any of the advertised products.

Straydog
Guest

Michael Robinson Is part of a group called Monday Morning which promotes hundreds of great plans to get you RICH. and Each plan happens to cost you $1950.00 to peek at them. But guess who is making the money on all these plans ???

Add a Topic
1251
trevor martin
Guest

Money morning is raking in the money and everyone else loses. Stay away from them

Add a Topic
3415
Khushi Matta
Guest

Please don’t underestimate the power of cancer cell. No single drug will capture this disease. We have not discovered a convincing biomarker for different cancers. There is not a technology for selection of patients for chemotherapy.
Nevertheless, I wish you best of luck.

Add a Topic
3397
vagabond1213
Member
๐Ÿ‘4
vagabond1213

Could it be
PharmaMar?

Add a Topic
5350
vagabond1213
Guest
vagabond1213

Hate to seem unintelligent but my best guess on this is a company call Pharmacy Mar said to be merging with another company Zeltia. What I don’t understand is why would I buy through Michael Robinson when I could buy PHMMF through Scottrade?

Add a Topic
5456
Add a Topic
1251
Idrea
Guest
Idrea

Has Travis weighed in yet on this please?

Travis Johnson, Stock Gumshoe
Admin
๐Ÿ‘12118

Not recently. I think I commented when this was first teased as an “imminent” IPO (last year, maybe? Would have to check the timing). Don’t know the science or the drug’s prospects, but the notion of a private placement or special prospectus deal pre-IPO is basically silly unless the newsletter is somehow getting a great deal for investors (unlikely), since the stock already traded on a liquid foreign exchange.

Add a Topic
636
Add a Topic
5971
vagabond1213
Member
๐Ÿ‘4
vagabond1213

Thank you Travis. That was my question. Why wouldn’t I just buy the stock on another exchange if I wanted in.

Add a Topic
5971
WARREEN
Guest
WARREEN

Name of company developing ET-73

Bozo T. Clown
Guest
Bozo T. Clown

https://www.pharmamar.com – check out the Senior Management and see if any folks (like the Managing Director for Oncology) show up in the Robinson tout ๐Ÿ˜‰
plenty of Pharma Mar videos on You Tube, as well

Investigating natural sea-borne compounds is their business line, hence the name of the company Pharma as in Pharmacy , Mar as in “the sea”

Bozo T. Clown
Guest
Bozo T. Clown

from:

http://www.edisoninvestmentresearch.com/research/report/pharmamar/preview/

“The former Zeltia Group has restructured to reposition the company as primarily a pharmaceutical business ahead of a potential US IPO in H216. The new structure was achieved by a reverse merger whereby the oncology division PharmaMar absorbed the former parent company Zeltia, with one PharmaMar share exchanged for each Zeltia share. A US listing could strengthen the companyโ€™s financial position, and potentially enable the group to expand its US operations.”

Add a Topic
5456
Add a Topic
636
Add a Topic
5350
mphomm
Guest
mphomm

Has anyone found out what the company’s name is? How does one get in before the IPO, if possible?

Add a Topic
636
Travis Johnson, Stock Gumshoe
Admin
๐Ÿ‘12118

We had three different discussions running about this teaser pitch, I’ve collated them all into this one place. It was also discussed quite actively when it was pitched as ET-743 by the same publishers back in February of this year here.

Miceal
Member
๐Ÿ‘314
Miceal

PharmaMar (Madrid) some facts: Its oncology portfolio has been validated through global partnerships, eg J&J in the US and Taiho in Japan (for Yondelis) and Chugai in certain EU countries (for Aplidin). It has a pipeline of cancer drugs with strategic partners, e.g. Yondelis for soft tissue sarcoma in Japan and the US with profit growth from 2017. The 420-patient CORAIL Phase III trial of PM1183 in platinum-resistant ovarian cancer was cleared to continue in August after an interim futility analysis on the first 210 patients. Another pivotal study of PM1183 was initiated in August – the 600-patient Phase III… Read more ยป

Add a Topic
5350
Add a Topic
1029
Add a Topic
3397
Ben
Guest
Ben

Check this out: https://www.pharmamar.com/wp-content/uploads/2016/05/Corporate-Brochure_PharmaMar.pdf

Andy
Guest
Andy

I think this company used to carry the symbool KHL which kind of stood for keyhole limpet or something like that. I want to say Stellar Biotechnologies but before you plunk you money down check it out for yourself. I can’t be that brilliant if I actually bought in.

Travis Johnson, Stock Gumshoe
Admin
๐Ÿ‘12118

Different company, though Stellar was also pushed heartily by Robinson starting a couple years ago, also with an eye on an imminent US listing. It did get the US listing (SBOT), but that didn’t do much for the stock price on the end.

Add a Topic
5971
Egr2know
Guest
Egr2know

Though I initially fell for M Robinson’s teaser on Nvidia & then ended my subscription during the trial period, I REALLY resent their TOTAL GREED in their astronomically ridiculous subscription fees! I guess they figure they should be paid by the number of words!!!I also lose patience with their ENDLESS pitches on whatever they pitch about!!!!!

Add a Topic
1340
Marec
Guest
Marec

I found,as tempting as “Money Morning” makes these investments sound ? Plus with the usual presentation to indicate you’d better hurry,so to speak,with little else other then high fee’s and you can make a lot of money. I patiently investigated, researched and then monitored a few of their recommendations ,determining that I was glad I waited and monitored the understanding and performance of their recommendations. Frequently if things sound to good to be true ,more times then not ,they usually are ,and with that it should be enough to say ,most investment considerations merit further research,not allowing for impatience ,or… Read more ยป

Add a Topic
3415
Ben
Guest
Ben

Check out this..looks fishy?? https://www.pharmamar.com/wp-content/uploads/2016/05/Corporate-Brochure_PharmaMar.pdf

Caroline
Guest
Caroline

Ok guys just checked Nasdaq.com for FREE
There is one biotech coming up called advanced pharma wait until it comes to market ok losse a bit but at least liquid

SoGiAm
Member
๐Ÿ‘11361
spirit
Guest
spirit

Hi, Is there any news about the company behind the Nasdaq listing and ET-73? Is it Janssen Biotech or PharmaMar whose support does not respond unfortunately to my questions. PharmaMar has been listed in Nasdaq since March 2016. Or is it another company? Thank you very much and kind regards from Germany

Add a Topic
5350
Add a Topic
5350
klingo88
Guest
klingo88

Hey,
what ist mit Imagin Medical Aktie ?

Curious
Guest
Curious

Has anyone heard further info on ET-73? Received another email from Money Morning touting the “IPO”, but I thought that already happened. Also, are they talking about PharmaMar or Janssen…I assumed they were talking about PharmaMar.

Add a Topic
3415
Add a Topic
636
Add a Topic
5350
Travis Johnson, Stock Gumshoe
Admin
๐Ÿ‘12118

Must be a rerun on their part… Janssen doesn’t usually get teased for anything, they’re just a division of Goliath JNJ.